Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
NAGE
$2.74
-1.97%
NAGE
· Niagen Bioscience, Inc.
$2.74
-0.06 (-1.97%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$241.33M
Shares
79.13M
Volume · Oct 5
62.29K
Avg daily vol (3M)
599K
All webcasts
Earnings call · FY2024 Q2
Niagen Bioscience, Inc. (NAGE) Q2 2024 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$22.74M
+11.9% YoY
Diluted EPS
$0.00
Gross margin
60.2%
-0.6 pp YoY
Net income
-$15,000
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 7, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue growth
Initiated
full year 2024
|
10% – 15% | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2024 · complete as-filed document